Director Share Dealings

RNS Number : 7411O

Futura Medical PLC

24 September 2013

 



For Immediate Release

24 September 2013

Futura Medical plc

("Futura" or "the Company")

Director Share Dealings

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has received notification of the following dealing which took place on 23 September 2013.

David Davies, Chief Development Officer, exercised options over 20,000 new ordinary shares of 0.2p each in the Company at a price of 40.50 pence per share and sold 20,000 of the ordinary shares at a price of 70.00 pence per share to satisfy tax obligations and option exercise costs.

Following the transactions the Director's holding in ordinary shares in the Company for the purposes of the AIM Rules for Companies is 751,306 shares (0.97% of the Company's issued share capital).

The 20,000 new ordinary shares issued raised £8,100 for the Company and shall rank pari passu with the existing issued ordinary shares of the Company.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Cenkos Securities plc
Bobbie Hilliam	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

RDSUSAKROBAKURR